logo
Plus   Neg
Share
Email
Comment

ADTRAN Revises Q1 Forecast - Quick Facts

ADTRAN, Inc. (ADTN) said it now expects first-quarter earnings per share to range from $0.17 to $0.20. Non-GAAP earnings per share for the quarter are expected to range from $0.22 to $0.25.

Revenue for the first quarter is currently expected to range from $130 million to $135 million.

ADTRAN chief executive officer Tom Stanton, said, "Two issues impacted us in the first quarter. The first was a slower than normal start to the seasonal buying pattern at some of our carrier customers. The second, which had a greater impact, was a delay in both the start and ramp of orders from a carrier customer due to new system implementations. Order rates for the month of March have substantially improved and we are encouraged that the prior slowdown that we experienced is behind us."

ADTRAN noted that acquisition related expenses, amortizations and adjustments related to the acquisition of Bluesocket, Inc. and the planned acquisition of the NSN Broadband Access business is estimated to reduce earnings per share by $0.02 for the first quarter 2012. Stock-based compensation expense is estimated to reduce earnings per share by $0.03 for quarter, the company added.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amid a government shutdown, the Senate voted Monday to move forward on a short-term spending bill to re-open the government. The Senate voted 81 to 18 in favor of limiting debate on the bill, which would fund the government through February 8th. Opera, a web browser for Windows, macOS, and Linux operating systems, has added cryptocurrency mining protection to its mobile browsers. It is part of the browser's ad blocker function. In its desktop-based versions, Opera had introduced cryptocurrency miner protection in early January. French drug giant Sanofi SA Monday announced an agreement to buy US-based hemophilia drugmaker Bioverativ Inc. (BIVV) for around $11.6 billion. The deal expands Sanofi's presence in specialty care and strengthens leadership in rare diseases. Sanofi shares were losing around 4 percent in the early morning trading in Paris.
comments powered by Disqus
Follow RTT